PERSPECTA

News from every angle

Results for "Anthropic’s Mythos AI"

17 stories found

Anthropic's Mythos AI Deemed Too Dangerous for Public Release
ScienceThe Guardiannzzforbes4mo ago3 sources

Anthropic's Mythos AI Deemed Too Dangerous for Public Release

Anthropic's new AI model, Mythos, has reportedly been withheld from public release due to concerns over its potential dangers and "extensional risks." This has drawn attention from industry leaders, including the Goldman Sachs chief, who expressed awareness of the risks.

Anthropic's Mythos AI Sparks Cybersecurity Concerns
TechnologyThe Guardiancnbcindex-hr3mo ago3 sources

Anthropic's Mythos AI Sparks Cybersecurity Concerns

Anthropic's new AI model, Mythos, has generated significant cybersecurity concerns and 'hysteria' among experts. Discussions are ongoing regarding the potential dangers and threats posed by the technology.

Japan Forms Task Force on AI Cyberattack Risks
Technologystraits-timeschannel-news-asia3mo ago2 sources

Japan Forms Task Force on AI Cyberattack Risks

Japan is establishing a task force to address potential cyberattack risks and broader security concerns stemming from artificial intelligence, specifically mentioning Anthropic's Mythos AI. The initiative aims to safeguard against emerging threats posed by advanced AI technologies.

Anthropic Investigates Unauthorized Access to Mythos AI Amid Cyberattack Fears
TechnologyReutersbloombergFT+13The GuardianfazSCMPorfpublicoBusiness Insiderjapan-timesnaftemporiki+5 more3mo ago16 sources

Anthropic Investigates Unauthorized Access to Mythos AI Amid Cyberattack Fears

Anthropic is investigating reports of unauthorized users gaining access to its Mythos AI model, which has raised cybersecurity concerns. Central banks in Australia, New Zealand, and Japan are reportedly monitoring the AI model due to fears of potential cyberattacks.

Trump Signs Order to Fast-Track Psychedelic Drug Research
WorldwsjFTThe Guardian+33NPRCNNFox Newsyle-uutisetcbccnbcberlingskeSCMP+25 more4mo ago36 sources

Trump Signs Order to Fast-Track Psychedelic Drug Research

President Trump signed an executive order to accelerate the review and access to psychedelic drug treatments, including controversial substances like ibogaine. Podcaster Joe Rogan was present at the White House announcement, where Trump joked about wanting some for anxiety.